Comorbidities In Patients With Central Centrifugal Cicatricial Alopecia: A Case-Control Study

    November 2023 in “ International Journal of Dermatology ”
    Tejas P. Joshi, Anthony Duruewuru, Danielle Garcia, Nabor Stephen Mireles, Paulina Truong, Clay J. Cockerell
    Image of study
    TLDR Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.
    This study investigates comorbidities in patients with central centrifugal cicatricial alopecia (CCCA) using data from the National Institute of Health's All of Us research program. The nested case-control study included 201 CCCA patients and matched controls. Findings revealed that CCCA patients had significantly higher odds of metabolic abnormalities such as hyperlipidemia (OR: 5.20), hypertension (OR: 8.62), and type 2 diabetes (OR: 5.66). They also had increased odds of autoimmune conditions (OR: 4.92) and atopic conditions like allergic rhinitis (OR: 6.03), asthma (OR: 3.55), and atopic dermatitis (OR: 4.94). Additionally, CCCA patients showed a higher prevalence of anxiety and depression. The study suggests that shared inflammatory pathways may mediate CCCA and its comorbidities, and highlights the potential role of Th2 inflammation. The findings underscore the importance of comprehensive care for CCCA patients, including screening for these comorbidities.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 113 results
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      by nkrata in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 3 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

      community scarring alopecia awareness in this community

      in Chat  33 upvotes 3 years ago
      Lichen Planopilaris (LPP), a form of permanent hair loss, which can be mistaken for seborrheic dermatitis and is characterized by scalp itching, burning, redness, and dandruff. Treatment options discussed include steroidal creams, finasteride, minoxidil, and RU58841.

    Related Research

    1 / 1 results